Joseph Celestino
0000-0002-7758-1558
Publication & Citation Trends
Publications
0 total
Abstract 6522: Novel serum biomarkers that detect ovarian cancer recurrence earlier than CA125
Cited by 0
Semantic Scholar
Abstract 3907: Molecular determinants of response in laparoscopically triaged advanced ovarian cancer.
Cited by 0
Semantic Scholar
Abstract 1041: Extracellular vesicle-associated noncanonical ORFs as biomarkers of surgical outcome and chemoresistance in ovarian cancer
Cited by 0
Semantic Scholar
Abstract 6520: Intratumoral microbiome profiling using high-depth whole-genome sequencing highlighted Cutibacterium acnes in chemoresistance in ovarian cancer
Cited by 0
Semantic Scholar
Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial.
Cited by 5
Semantic Scholar
Mitochondrial defects and metabolic vulnerabilities in Lynch syndrome-associated MSH2-deficient endometrial cancer OA
Cited by 2
Semantic Scholar
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer OA
Cited by 15
Semantic Scholar
Abstract B024: Immune exhaustion and reversal of progestin-related immune modulation in adaptive resistance to levonorgestrel intrauterine device for treatment of atypical hyperplasia and early endometrial cancer
Cited by 0
Semantic Scholar
Research Topics
Ovarian cancer diagnosis and treatment
(76)
Endometrial and Cervical Cancer Treatments
(25)
Advanced Proteomics Techniques and Applications
(17)
Cancer Genomics and Diagnostics
(17)
PARP inhibition in cancer therapy
(15)
Affiliations
Gynecologic Oncology Group
Memorial Sloan Kettering Cancer Center
The University of Texas MD Anderson Cancer Center
Harvard University
Baylor College of Medicine